Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
UKALL R2 - Acute Lymphoblastic Leukaemia trial
Source of recordUK Trials
ISRCTNISRCTN95257778
Date ISRCTN assigned06/04/2000
Local reference number(s)G8223452
Public titleUKALL R2 - Acute Lymphoblastic Leukaemia trial
Scientific title
AcronymUKALL R2
Disease/condition/study domainAcute Lymphoblastic Leukaemia
Study hypothesisTo compare continuing chemotherapy with unrelated donor BMT in relapsed childhood ALL following a common re-induction and consolidation regimen.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaThey are children under 15 years at original diagnosis and treated on UKALL trials or pilot studies with first relapse less than 4 years from the start of treatment of ALL at any site and no suitable related bone marrow treatment (BMT) donor is available
Participants - exclusion criteria1. They are multiply relapsed patients
2. They have a prior history of toxicity or organ damage such that completion of the protocol is felt unlikely at the outset
3. They have had an isolated CNS or testicular relapse more than 6 months off treatment.
Patient information material
Anticipated start date01/02/1995
Anticipated end date30/09/2008
Status of trialOngoing
Target number of participants200 - Closed to recruitment - in long term follow-up
InterventionsContinuing chemotherapy/unrelated donor BMT
Primary outcome measure(s)Survival, disease free survival
Secondary outcome measure(s)Not provided at time of registration
PublicationsResults on http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15982346
Sources of fundingUK Medical Research Council
Sponsor nameMedical Research Council (UK)
Sponsor details20 Park Crescent
London
United Kingdom
W1B 1AL
Sponsor telephone+44 (0)20 7636 5422
Sponsor fax+44 (0)20 7436 6179
Sponsor emailclinical.trial@headoffice.mrc.ac.uk
Sponsor websitehttp://www.mrc.ac.uk
Contact nameDr PJ Darbyshire
Contact detailsThe Children's Hospital
Ladywood Middleway
Birmingham
United Kingdom
B16 8ET
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN95257778
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central